JP2007519632A5 - - Google Patents

Download PDF

Info

Publication number
JP2007519632A5
JP2007519632A5 JP2006547433A JP2006547433A JP2007519632A5 JP 2007519632 A5 JP2007519632 A5 JP 2007519632A5 JP 2006547433 A JP2006547433 A JP 2006547433A JP 2006547433 A JP2006547433 A JP 2006547433A JP 2007519632 A5 JP2007519632 A5 JP 2007519632A5
Authority
JP
Japan
Prior art keywords
seq
antibody
taho
polypeptide
amino acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2006547433A
Other languages
English (en)
Japanese (ja)
Other versions
JP4658967B2 (ja
JP2007519632A (ja
Filing date
Publication date
Priority claimed from PCT/US2004/038262 external-priority patent/WO2005049075A2/en
Priority claimed from US10/989,826 external-priority patent/US20050238650A1/en
Application filed filed Critical
Priority claimed from PCT/US2004/043514 external-priority patent/WO2005063299A2/en
Publication of JP2007519632A publication Critical patent/JP2007519632A/ja
Publication of JP2007519632A5 publication Critical patent/JP2007519632A5/ja
Application granted granted Critical
Publication of JP4658967B2 publication Critical patent/JP4658967B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

JP2006547433A 2003-12-24 2004-12-21 造血系起源の腫瘍の治療のための組成物と方法 Expired - Lifetime JP4658967B2 (ja)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US53242603P 2003-12-24 2003-12-24
PCT/US2004/038262 WO2005049075A2 (en) 2003-11-17 2004-11-16 Compositions and methods for the treatment of tumor of hematopoietic origin
US10/989,826 US20050238650A1 (en) 2002-04-17 2004-11-16 Compositions and methods for the treatment of tumor of hematopoietic origin
PCT/US2004/043514 WO2005063299A2 (en) 2003-12-24 2004-12-21 Compositions and methods for the treatment of tumor of hematopoietic origin

Related Child Applications (2)

Application Number Title Priority Date Filing Date
JP2010037990A Division JP2010154864A (ja) 2003-12-24 2010-02-23 造血系起源の腫瘍の治療のための組成物と方法
JP2010199100A Division JP2011019523A (ja) 2003-12-24 2010-09-06 造血系起源の腫瘍の治療のための組成物と方法

Publications (3)

Publication Number Publication Date
JP2007519632A JP2007519632A (ja) 2007-07-19
JP2007519632A5 true JP2007519632A5 (enExample) 2010-04-15
JP4658967B2 JP4658967B2 (ja) 2011-03-23

Family

ID=34743701

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2006547433A Expired - Lifetime JP4658967B2 (ja) 2003-12-24 2004-12-21 造血系起源の腫瘍の治療のための組成物と方法
JP2010037990A Pending JP2010154864A (ja) 2003-12-24 2010-02-23 造血系起源の腫瘍の治療のための組成物と方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2010037990A Pending JP2010154864A (ja) 2003-12-24 2010-02-23 造血系起源の腫瘍の治療のための組成物と方法

Country Status (6)

Country Link
US (1) US20080166294A1 (enExample)
EP (1) EP1696963A2 (enExample)
JP (2) JP4658967B2 (enExample)
AU (2) AU2004308972C1 (enExample)
CA (1) CA2551813C (enExample)
WO (1) WO2005063299A2 (enExample)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4776843B2 (ja) 1999-10-01 2011-09-21 イムノゲン インコーポレーティッド 免疫複合体及び化学療法剤を用いる癌治療用組成物及び方法
US7097840B2 (en) * 2000-03-16 2006-08-29 Genentech, Inc. Methods of treatment using anti-ErbB antibody-maytansinoid conjugates
US7317087B2 (en) 2002-03-25 2008-01-08 The Uab Research Foundation Members of the FC receptor homolog gene family (FCRH1-3, 6), related reagents, and uses thereof
US8088387B2 (en) 2003-10-10 2012-01-03 Immunogen Inc. Method of targeting specific cell populations using cell-binding agent maytansinoid conjugates linked via a non-cleavable linker, said conjugates, and methods of making said conjugates
CA2556752C (en) * 2004-02-23 2016-02-02 Genentech, Inc. Heterocyclic self-immolative linkers and conjugates
US7999077B2 (en) 2004-09-30 2011-08-16 The United States Of America As Represented By The Secretary Of The Department Of Health And Human Services IRTA2 antibodies and methods of use
EP1846449A4 (en) * 2005-01-12 2009-07-08 Medarex Inc IRTA-2 ANTIBODIES AND THEIR USE
RU2542449C2 (ru) * 2007-11-30 2015-02-20 Эндо Фармасьютикалз Солюшнз Инк. Композиции и способы лечения рака мочевого пузыря
US9879267B2 (en) * 2008-03-14 2018-01-30 Genentech, Inc. Genetic variations associated with drug resistance
NZ587706A (en) 2008-03-18 2012-12-21 Genentech Inc Combinations of an anti-her2 antibody-drug conjugate and chemotherapeutic agents, and methods of use
PE20120877A1 (es) 2009-04-01 2012-08-06 Genentech Inc ANTICUERPOS ANTI-FcRH5 E INMUNOCONJUGADOS
MA33256B1 (fr) 2009-04-01 2012-05-02 Genentech Inc Anticorps et immunoconjugués anti-fcrh5 et procédés d'utilisation
TW201302793A (zh) 2010-09-03 2013-01-16 Glaxo Group Ltd 新穎之抗原結合蛋白
WO2013048243A1 (en) 2011-09-29 2013-04-04 Apo-T B.V. Multi-specific binding molecules targeting aberrant cells
EP2802356A1 (en) * 2012-01-13 2014-11-19 Apo-T B.V. Aberrant cell-restricted immunoglobulins provided with a toxic moiety
US10260089B2 (en) 2012-10-29 2019-04-16 The Research Foundation Of The State University Of New York Compositions and methods for recognition of RNA using triple helical peptide nucleic acids
TWI725931B (zh) 2013-06-24 2021-05-01 美商建南德克公司 抗ｆｃｒｈ５抗體
HUE050159T2 (hu) 2013-12-17 2020-11-30 Genentech Inc Anti-CD3 antitestek és alkalmazási eljárások
US10323094B2 (en) 2015-06-16 2019-06-18 Genentech, Inc. Humanized and affinity matured antibodies to FcRH5 and methods of use
CA3252263A1 (en) 2022-02-09 2025-07-07 National Institutes Of Biomedical Innovation, Health And Nutrition ANTIBODY OR FRAGMENT OF IT BINDING TO FCRL1

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5208020A (en) * 1989-10-25 1993-05-04 Immunogen Inc. Cytotoxic agents comprising maytansinoids and their therapeutic use
US5686072A (en) * 1992-06-17 1997-11-11 Board Of Regents, The University Of Texas Epitope-specific monoclonal antibodies and immunotoxins and uses thereof
JP2004522402A (ja) * 1999-06-02 2004-07-29 ジェネンテック・インコーポレーテッド 同一のものをコードする分泌及び膜貫通ポリペプチドと核酸
DE19926475A1 (de) * 1999-06-10 2000-12-14 Ktb Tumorforschungs Gmbh Träger-Pharmaka-Konjugate
ES2586850T3 (es) * 1999-11-29 2016-10-19 The Trustees Of Columbia University In The City Of New York Aislamiento de cinco genes novedosos que codifican nuevos melanomas de tipo receptor de Fc implicados en la patogénesis del linfoma/melanoma
US20030078396A1 (en) * 2000-03-01 2003-04-24 Corixa Corporation Compositions and methods for the detection, diagnosis and therapy of hematological malignancies
US7317087B2 (en) * 2002-03-25 2008-01-08 The Uab Research Foundation Members of the FC receptor homolog gene family (FCRH1-3, 6), related reagents, and uses thereof
CA2485983A1 (en) * 2002-05-15 2003-11-27 Avalon Pharmaceuticals Cancer-linked gene as target for chemotherapy
NZ576411A (en) * 2003-11-17 2010-04-30 Genentech Inc Compositions and methods for the treatment of tumor of hematopoietic origin

Similar Documents

Publication Publication Date Title
JP5587841B2 (ja) 造血系起源の腫瘍の治療のための組成物と方法
JP4822710B2 (ja) 腫瘍の診断と治療のための組成物と方法
JP4703567B2 (ja) 膠細胞起源の腫瘍の診断と治療のための組成物と方法
US20050238650A1 (en) Compositions and methods for the treatment of tumor of hematopoietic origin
JP2010154864A (ja) 造血系起源の腫瘍の治療のための組成物と方法
JP2010154864A6 (ja) 造血系起源の腫瘍の治療のための組成物と方法
US20110045005A1 (en) Compositions and methods for the treatment of tumor of hematopoietic origin
JP2005536190A (ja) 腫瘍の診断と治療のための組成物と方法
JP2006510735A (ja) 腫瘍の診断と治療のための組成物と方法
JP2006516089A (ja) 腫瘍の診断と治療のための組成物と方法
JP2008137989A (ja) 腫瘍の診断と治療のための組成物と方法
US20070207142A1 (en) Compositions and methods for the treatment of tumor of hematopoietic origin
US7754441B2 (en) Compositions and methods for the treatment of tumor of hematopoietic origin
JP2007521791A (ja) 腫瘍の診断と治療のための組成物と方法
US7888478B2 (en) Compositions and methods for the treatment of tumor of hematopoietic origin
US20050226869A1 (en) Compositions and methods for the treatment of tumor of hematopoietic origin
US7858330B2 (en) Compositions and methods for the treatment of tumor of hematopoietic origin
JP2006104212A (ja) 腫瘍の診断と治療のための組成物と方法
JP2006516655A (ja) 腫瘍の診断と治療のための組成物と方法
JP2007512019A (ja) 腫瘍の診断と治療のための組成物と方法
US20060002943A1 (en) Compositions and methods for the treatment of tumor of hematopoietic origin
JP2011019523A (ja) 造血系起源の腫瘍の治療のための組成物と方法
JP2005513084A (ja) 腫瘍の診断と治療のための組成物及び方法
HK1165811A (en) Antibodies against cd79b for the treatment of tumor of hematopoeitic origin
HK1153931B (en) Antibody against cd22 for the treatment of tumour of hematopoietic origin